Application 090291
- Type
- ANDA
- Sponsor
- FOSUN PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CEFEPIME HYDROCHLORIDE | CEFEPIME HYDROCHLORIDE | INJECTABLE;INJECTION | EQ 500MG BASE/VIAL | No | No |
| 002 | CEFEPIME HYDROCHLORIDE | CEFEPIME HYDROCHLORIDE | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL | No | No |
| 003 | CEFEPIME HYDROCHLORIDE | CEFEPIME HYDROCHLORIDE | INJECTABLE;INJECTION | EQ 2GM BASE/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090291-001 | CEFEPIME HYDROCHLORIDE | CEFEPIME HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | ||
| A090291-002 | CEFEPIME HYDROCHLORIDE | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | ||
| A090291-003 | CEFEPIME HYDROCHLORIDE | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090291-002 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090291-003 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A090291-001 | CEFEPIME HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A090291-002 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A090291-003 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A090291-001 | CEFEPIME HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A090291-002 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A090291-003 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A090291-001 | CEFEPIME HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A090291-002 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A090291-003 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A090291-001 | CEFEPIME HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A090291-002 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A090291-003 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A090291-001 | CEFEPIME HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A090291-002 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A090291-003 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A090291-001 | CEFEPIME HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A090291-002 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A090291-003 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A090291-001 | CEFEPIME HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A090291-002 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A090291-003 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A090291-001 | CEFEPIME HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A090291-002 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A090291-003 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A090291-001 | CEFEPIME HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A090291-002 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A090291-003 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A090291-001 | CEFEPIME HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A090291-002 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A090291-003 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A090291-001 | CEFEPIME HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A090291-002 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A090291-003 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A090291-001 | CEFEPIME HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A090291-002 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A090291-003 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A090291-001 | CEFEPIME HYDROCHLORIDE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A090291-002 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2010-12-21 | c0c555d07b60… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CEFEPIME HYDROCHLORIDE AND DEXTROSE | CEFEPIME HYDROCHLORIDE | B. Braun Medical Inc. | 57517a0e-ec1b-4605-a7cc-7e3801158ec9 | 2026-04-07 | Warnings, Adverse reactions | CEFEPIME HYDROCHLORIDE |
| Cefepime Hydrochloride | CEFEPIME HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | b9914e7e-13f6-42d4-9cbb-8c7ed1ce7a01 | 2025-10-14 | Warnings, Adverse reactions | Cefepime Hydrochloride CEFEPIME HYDROCHLORIDE |
| Cefepime Hydrochloride | CEFEPIME HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | f64c181e-28c5-48ab-aa67-5ca0e3fd079c | 2025-06-30 | Warnings, Adverse reactions | Cefepime Hydrochloride CEFEPIME HYDROCHLORIDE |
| Cefepime | CEFEPIME HYDROCHLORIDE | Qilu Pharmaceutical Co., Ltd. | 80b4c811-4a71-47fb-8565-85ce9d0f782c | 2021-11-15 | Warnings, Adverse reactions | CEFEPIME HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.